Guru Ownership Trend
Guru Analysis for AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $40.24 M.
Top institutional holders include Jefferies Group and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $8.79 M net inflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 36.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for AbCellera Biologics Inc. (ABCL)
Major holders include Jefferies Group ($9.58 M), Paul Tudor Jones ($7.93 M), Renaissance Technologies (RenTech) ($5.27 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 7.68 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.79 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ABCL. The total reported sell value was $3.07 M.
Yes, 1 managers opened new positions in ABCL, and 2 increased their existing holdings. The total reported buy value was $11.85 M.